{"id":562604,"date":"2021-09-10T13:14:01","date_gmt":"2021-09-10T13:14:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=562604"},"modified":"2021-09-10T13:14:01","modified_gmt":"2021-09-10T13:14:01","slug":"vasomotor-symptoms-hot-flashesnight-sweats-market-analysis-market-size-share-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/vasomotor-symptoms-hot-flashesnight-sweats-market-analysis-market-size-share-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight_562604.html","title":{"rendered":"Vasomotor Symptoms (Hot Flashes\/Night Sweats) Market Analysis, Market Size &#038; Share, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1631247491.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Vasomotor Symptoms (Hot Flashes\/Night Sweats) Market Analysis, Market Size &amp; Share, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1631247491.png\" alt=\"Vasomotor Symptoms (Hot Flashes\/Night Sweats) Market Analysis, Market Size &amp; Share, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>DelveInsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u2018Vasomotor symptoms (Hot flashes\/Night sweats)\u2013Market Insights, Epidemiology and Market Forecast\u20142030\u2019 report delivers an in-depth understanding of the Vasomotor symptoms including Hot flashes or night sweats, historical and forecasted epidemiology as well as the Vasomotor symptoms (Hot flashes\/Night sweats) market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>DelveInsight has launched a new report on <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/vasomotor-symptoms-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">&#8220;Vasomotor Symptoms (Hot Flashes\/Night Sweats) &#8211; Market Insights, Epidemiology, and Market Forecast-2030&rdquo;.<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight&rsquo;s<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/vasomotor-symptoms-market\"> &ldquo;<strong>Vasomotor Symptoms (Hot Flashes\/Night Sweats) &ndash; Market Insights, Epidemiology, and Market Forecast-2030<\/strong>&Prime; <\/a>report deliver an in-depth understanding of the Vasomotor Symptoms (Hot Flashes\/Night Sweats), historical and forecasted epidemiology as well as the Vasomotor Symptoms (Hot Flashes\/Night Sweats) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/f31a4076cbc81ab47fcbb0eb303735bd.jpg\" alt=\"\" \/><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Some of the key facts of the Report:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">The total prevalent population of Vasomotor Symptoms associated with post-menopause in 7MM countries was 41,096,968 in 2017. The prevalent population of Hot Flashes Associated with menopause in 7MM countries is expected to increase.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">As per the estimates, the United States has the highest prevalent population of Hot Flashes associated with Post Menopause with 18,926,632 cases in 2017. Japan had the lowest prevalent population with 4,553,108 prevalent cases of hot flashes in 2017.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Key benefits of the report:<\/strong><\/p>\n<ol style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Vasomotor Symptoms (Hot Flashes\/Night Sweats)&nbsp; market report covers a descriptive overview and comprehensive insight of the Vasomotor Symptoms (Hot Flashes\/Night Sweats)&nbsp; epidemiology and Vasomotor Symptoms (Hot Flashes\/Night Sweats)&nbsp; market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">The Vasomotor Symptoms (Hot Flashes\/Night Sweats) market report provides insights on the current and emerging therapies.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Vasomotor Symptoms (Hot Flashes\/Night Sweats) market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">The Vasomotor Symptoms (Hot Flashes\/Night Sweats) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Vasomotor Symptoms (Hot Flashes\/Night Sweats) market.<\/p>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Got queries? Click here to know more about <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/vasomotor-symptoms-market\">Vasomotor Symptoms (Hot Flashes\/Night Sweats) Market Landscape.<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/vasomotor-symptoms-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\">Vasomotor Symptoms (Hot Flashes\/Night Sweats) Overview<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Vasomotor Symptoms (Vasomotor Symptoms) is one of the major symptoms of menopause that principally include hot flashes (HF) and night sweats (NS) during menopause and occurs in the majority of women across the globe. A woman with Vasomotor Symptoms experiences abundant heat accompanied by sweating and flushing, especially around the head, neck, chest, and upper back region. Vasomotor Symptoms result from temperature dysfunction that occurs due to changes in gonadal hormones.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>The key players involved in the Vasomotor Symptoms (Hot Flashes\/Night Sweats)&nbsp; market:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Astellas Pharma<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Nerre Therapeutics<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Fervent Pharmaceuticals<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Mithra Pharmaceuticals<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">And others<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>The launch of the emerging therapies is expected to significantly impact the Vasomotor Symptoms (Hot Flashes\/Night Sweats) treatment scenario in the upcoming years:-<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Drug covered<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Fezolinetant<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">NT-814<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">FP-101&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Donesta<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">And others.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Request a free sample report <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/vasomotor-symptoms-market\">@ Vasomotor Symptoms (Hot Flashes\/Night Sweats) Market Outlook<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">1. Report Introduction<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">4. Vasomotor Symptoms (Hot Flashes\/Night Sweats) Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">5. Vasomotor Symptoms (Hot Flashes\/Night Sweats) Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">6. Vasomotor Symptoms (Hot Flashes\/Night Sweats) Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">7. Vasomotor Symptoms (Hot Flashes\/Night Sweats) Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">8. Country-Specific Patient Population of Vasomotor Symptoms (Hot Flashes\/Night Sweats)&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">9. Vasomotor Symptoms (Hot Flashes\/Night Sweats) Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">11. Vasomotor Symptoms (Hot Flashes\/Night Sweats) Emerging Therapies<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">12. Vasomotor Symptoms (Hot Flashes\/Night Sweats)&nbsp; Market Outlook<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">13. Country-Wise Vasomotor Symptoms (Hot Flashes\/Night Sweats) Market Analysis (2017&ndash;2030)<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">17. Appendix<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">18. Vasomotor Symptoms (Hot Flashes\/Night Sweats) Report Methodology<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">21. About DelveInsight<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=vasomotor-symptoms-hot-flashesnight-sweats-market-analysis-market-size-share-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=vasomotor-symptoms-hot-flashesnight-sweats-market-analysis-market-size-share-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight Business Research LLP DelveInsight\u2019s \u2018Vasomotor symptoms (Hot flashes\/Night sweats)\u2013Market Insights, Epidemiology and Market Forecast\u20142030\u2019 report delivers an in-depth understanding of the Vasomotor symptoms including Hot flashes or night sweats, historical and forecasted epidemiology as well as the Vasomotor symptoms &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/vasomotor-symptoms-hot-flashesnight-sweats-market-analysis-market-size-share-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight_562604.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-562604","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/562604","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=562604"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/562604\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=562604"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=562604"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=562604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}